معرفی
Jane Sosabowski is a Professor in radionuclide imaging and therapy at Queen Mary University of London, leading research focused on developing radiopharmaceuticals for cancer imaging and therapy, particularly alpha particle emitters for targeted therapy and non-invasive imaging techniques for genetically modified cell therapies like CAR-T cells. Her work bridges preclinical and clinical research to advance cancer diagnostics and treatment.
- BSc (Hons), MSc, PhD in relevant biomedical disciplines
Her research integrates nuclear medicine with oncology and immunotherapy, emphasizing radiopharmaceutical development, in vivo imaging, and computational tools for disease modeling. Recent work includes machine learning applications to reduce animal use in pancreatic cancer studies and SPECT/PET imaging for CAR-T cell tracking.
The articles reflect a focus on radiopharmaceutical optimization, targeted therapy, immunotherapy imaging, and preclinical validation, with subfields spanning SPECT/CT methodology, CAR-T cell biodistribution, chelator chemistry, and machine learning-based disease quantification.
- Research England Policy Impact Award (2022)
Jane leads major grants including Neuroblastoma UK, Barts Charity, and Invicro LLC funding for radionuclide therapy and imaging projects. Her team at the Preclinical Imaging Core Facility at BCI collaborates on theragnostic vectors, gallium-68 PET services, and disease model validation.
